T14	Exp 41 74	its inhibitor I kappa B-alpha/MAD
T15	Exp 261 283	the stimulated release
T16	Exp 337 363	the spontaneous expression
T17	Exp 525 539	its components
T18	Exp 623 625	we
T19	Exp 635 644	the basis
T20	Exp 612 622	this study
T21	Exp 723 725	We
T22	Exp 779 810	the major cytoplasmic inhibitor
T23	Exp 1229 1234	which
T24	Exp 1189 1203	The expression
T25	Exp 1440 1454	the expression
T26	Exp 1609 1623	its tuberculin
T27	Exp 1662 1677	the degradation
T28	Exp 1701 1715	the expression
T29	Exp 1781 1795	the activation
R5	Coref Anaphora:T14 Antecedent:T30
R6	Coref Anaphora:T17 Antecedent:T31
R7	Coref Anaphora:T23 Antecedent:T7
R8	Coref Anaphora:T26 Antecedent:T32
T1	Protein 55 70	I kappa B-alpha
T2	Protein 71 76	MAD-3
T3	Protein 322 331	TNF-alpha
T4	Protein 367 372	IL-2R
T5	Protein 762 777	I kappa B-alpha
T6	Protein 936 951	I kappa B-alpha
T7	Protein 1207 1222	I kappa B-alpha
T8	Protein 1506 1510	IL-8
T9	Protein 1515 1524	IL-1 beta
T10	Protein 1613 1623	tuberculin
T11	Protein 1681 1696	I kappa B-alpha
T12	Protein 1719 1734	I kappa B-alpha
T30	Exp 0 10	Regulation
T31	Exp 494 520	Mycobacterium tuberculosis
T32	Exp 1589 1604	M. tuberculosis
